ストックスクリーナーアプリを入手
2.86
4.76%
0.13
アフターアワーズ：
2.98
0.12
+4.20%
前日終値:
$2.73
開ける：
$2.77
24時間の取引高:
143.38K
Relative Volume:
0.24
時価総額：
$5.72M
収益：
$32.96M
当期純損益:
$-4.23M
株価収益率:
-1.7024
EPS:
-1.68
ネットキャッシュフロー:
$-14.00M
1週間 パフォーマンス:
+21.19%
1か月 パフォーマンス:
-1.04%
6か月 パフォーマンス:
-77.45%
1年 パフォーマンス:
-99.49%
1日の値動き範囲:
$2.71
$2.91
1週間の範囲:
$2.20
$3.3154
52週間の値動き範囲:
$2.1056
$608.00
Sunshine Biopharma Inc Stock (SBFM) Company Profile
名前
Sunshine Biopharma Inc
セクター
電話
954-515-0810
住所
333 LAS OLAS WAY, FORT LAUDERDALE
SBFM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
2.86 | 5.72M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
175.25 | 79.07B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.66 | 43.68B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.62 | 43.18B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.01B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
13.09 | 15.62B | 15.05B | -883.30M | 1.89B | -0.74 |
Sunshine Biopharma Inc (SBFM) 最新ニュース
SBFM (Sunshine Biopharma) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Operating Income : $-4.91 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Change In Working Capital : $-7.80 Mil (TTM As of Sep. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Debt-to-Equity : 0.02 (As of Sep. 2024) - GuruFocus.com
Alkermes (ALKS) Stock Surges Over 5% Amid Strong Financial Perfo - GuruFocus.com
Stock market today: SKK Holdings Limited +81.83%, Palladyne AI Corp. +50.51% among top gainers in early trading - Business Upturn
Sunshine Biopharma launches generic prescription drug - TipRanks
Sunshine Biopharma launches generic liver drug in Canada - Investing.com
Sunshine Biopharma Launches a New Generic Prescription Drug - AccessWire
Sunshine Biopharma Launches New Generic Drug in $933M Growing Market | SBFM Stock News - StockTitan
Sunshine Biopharma stock hits 52-week low at $2.3 amid sharp decline - Investing.com Canada
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com
CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com
Sunshine Biopharma Inc. Warrant (SBFMW) Quarterly 10-Q Report - Quartz
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - AccessWire
SBFM (Sunshine Biopharma) Shares Outstanding (EOP) : 1.17 Mil (As of Jun. 2024) - GuruFocus.com
Canopy Growth Corporation (CGC) Stock Declines Amid Financial Re - GuruFocus.com
Bloomin’ Brands (NASDAQ:BLMN) Rating Increased to Hold at StockNews.com - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
First Citizens Bancshares (OTC:FIZN) Stock Price Down 4.3% – Should You Sell? - Defense World
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
JATT Acquisition (NYSE:JATT) Trading Down 2.7% – Should You Sell? - Defense World
Sunshine Biopharma Strengthens Leadership with New Executive Agreements - TipRanks
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 66.8% in September - MarketBeat
Sunshine Biopharma announces Nora Pharma launch of two new generic drugs - TipRanks
Sunshine Biopharma expands generic drug portfolio - Investing.com
Sunshine Biopharma’s Nora Pharma launches two generic prescription drugs - TipRanks
Sunshine Biopharma Launches Two New Generic Prescription Drugs - AccessWire
A new trading data show Sunshine Biopharma Inc (SBFM) is showing positive returns. - SETE News
Sunshine Biopharma Inc (SBFM) Stock: Navigating a Year of Volatility - The InvestChronicle
How is SBFM’s stock performing after recent trades? - US Post News
Sunshine Biopharma meets Nasdaq compliance requirements By Investing.com - Investing.com Australia
Sunshine Biopharma meets Nasdaq compliance requirements - Investing.com
Sunshine Biopharma announces publication of coronavirus research results - TipRanks
Sunshine Biopharma reports potential SARS-CoV-2 treatment By Investing.com - Investing.com Canada
Sunshine Biopharma reports potential SARS-CoV-2 treatment - Investing.com
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry - Lelezard
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth - GlobeNewswire
Is Sunshine Biopharma, Inc. (SBFM) The Best Rated Penny Stock To Buy According to Analysts? - MSN
10 Best Rated Penny Stocks To Buy According to Analysts - Insider Monkey
Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada - AccessWire
Sunshine Biopharma’s Revenues and Profits Surge - TipRanks
SBFM (Sunshine Biopharma) Operating Income : $-4.31 Mil (TTM As of Mar. 2024) - GuruFocus.com
Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61% - AccessWire
Sunshine Biopharma (NASDAQ:SBFM) Issues Quarterly Earnings Results - Defense World
Sunshine Biopharma (NASDAQ:SBFM) Shares Down 9.6% - MarketBeat
SBFM (Sunshine Biopharma) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Mar. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Cyclically Adjusted PS Ratio : 0.00 (As of Aug. 16, 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Financial Strength : 7 (As of Mar. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Long-Term Debt & Capital Lease Ob - GuruFocus.com
Sunshine Biopharma Inc (SBFM) 財務データ
収益
当期純利益
現金流量
EPS
1.11%
0.61%
大文字化:
|
ボリューム (24 時間):